Granulocyte colony-stimulating factor: A novel mediator of T cell tolerance

Journal of Immunology

Volumn 175, Issue 11, 2005, Pages 7085-7091

  Rutella, Sergio ^a,c   Zavala, Flora ^b   Danese, Silvio ^a   Kared, Hassen ^b   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CNRS   (France)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR;

CELL DIFFERENTIATION; CLINICAL TRIAL; CYTOKINE RELEASE; DENDRITIC CELL; DIABETES MELLITUS; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; ENTERITIS; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH2 CELL;

EID: 28244481507     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.11.7085     Document Type: Short Survey

References (93)

1. Demetri, G. D., and J. D. Griffin. 1991. Granulocyte colony-stimulating factor and its receptor. Blood 78: 2791-2808.
2. Gutierrez-Delgado, F., and W. Bensinger. 2001. Safety of granulocyte colony-stimulating factor in normal donors. Curr. Opin. Hematol. 8: 155-160.
3. Anderlini, P., D. Przeplorka, R. Champlin, and M. Korbling. 1996. Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals. Blood 88: 2819-2825.
4. Rutella, S., C. Rumi, S. Sica, and G. Leone. 1999. Recombinant human granulocyte colony-stimulating factor (rHuG-CSF): effects on lymphocyte phenotype and function. J. Interferon Cytokine Res. 19: 989-994.
5. Franzke, A., W. Piao, J. Lauber, P. Gatzlaff, C. Konecke, W. Hansen, A. Schmitt-Thomsen, B. Hertenstein, J. Buer, and A. Ganser. 2003. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood 102: 734-739.
6. Sloand, E. M., S. Kim, J. P. Maciejewski, F. Van Rhee, A. Chaudhuri, J. Barrett, and N. S. Young. 2000. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 95: 2269-2274.
7. Morikawa, K., S. Morikawa, M. Nakamura, and T. Miyawaki. 2002. Characterization of granulocyte colony-stimulating factor receptor expressed on human lymphocytes. Br. J. Haematol. 118: 296-304.
8. Boneberg, E. M., L. Hareng, F. Gantner, A. Wendel, and T. Hartung. 2000. Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon γ. Blood 95: 270-276.
9. Boneberg, E. M., and T. Hartung. 2002. Granulocyte colony-stimulating factor attenuates LPS-stimulated IL-1β release via suppressed processing of proIL-1β, whereas TNF-α release is inhibited on the level of proTNF-α formation. Eur. J. Immunol. 32: 1717-1725.
10. Hartung, T., W. D. Docke, F. Gantner, G. Krieger, A. Sauer, P. Stevens, H. D. Volk, and A. Wendel. 1995. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85: 2482-2489.
11. Pollmacher, T., C. Korth, J. Mullington, W. Schreiber, J. Sauer, H. Vedder, C. Galanos, and F. Holsboer. 1996. Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and on the in vivo host response to endotoxin in healthy men. Blood 87: 900-905.
12. Kitabayashi, A., M. Hirokawa, Y. Hatano, M. Lee, J. Kuroki, H. Niitsu, and A. B. Miura. 1995. Granulocyte colony-stimulating factor down-regulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor α production. Blood 86: 2220-2227.
13. Fujii, K., F. Ishimaru, T. Kozuka, K. Matsuo, K. Nakase, I. Kataoka, T. Tabayashi, K. Shinagawa, K. Ikeda, M. Harada, and M. Tanimoto. 2004. Elevation of serum hepatocyte growth factor during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization. Br. J. Haematol. 124: 190-194.
14. Rutella, S., C. Rumi, U. Testa, S. Sica, L. Teofili, R. Marrucci, C. Peschle, and G. Leone. 1997. Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 receptor antagonist. Bone Marrow Transplant. 20: 355-364.
15. Rondelli, D., D. Raspadori, C. Anasetti, G. Bandini, F. Re, M. Arpinati, M. Stanzani, A. Morelli, C. Baccini, A. Zaccaria, et al. 1998. Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells. Bone Marrow Transplant. 22: 631-637.
16. Talmadge, J. E., E. C. Reed, A. Kessinger, C. A. Kuszynski, G. A. Perry, C. L. Gordy, K. C. Mills, M. L. Thomas, S. J. Pirruccello, B. A. Lerheby, et al. 1996. Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation. Bone Marrow Transplant. 17: 101-109.
17. Rutella, S., C. Rumi, M. B. Lucia, S. Sica, R. Cauda, and G. Leone. 1998. Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness. Exp. Hematol. 26: 1024-1033.
18. Rutella, S., C. Rumi, L. Pierelli, R. Morosetti, S. Sica, G. Bonanno, G. Scambia, and G. Leone, 2000. Granulocyte colony-stimulating factor perturbs lymphocyte mitochondrial function and inhibits cell cycle progression. Exp. Hematol. 28: 612-625.
19. Rutella, S., L. Pierelli, C. Rumi, G. Bonanno, M. Marone, S. Sica, E. Capoluongo, F. Ameglio, G. Scambia, and G. Leone. 2001. T cell apoptosis induced by granulocyte colony-stimulating factor is associated with retinoblastoma protein phosphorylation and reduced expression of cyclin-dependent kinase inhibitors. Exp. Hematol. 29: 401-415.
20. Tanaka, J., M. Mielcarek, and B. Torok-Storb. 1998. Impaired induction of the CD28-responsive complex in granulocyte colony-stimulating factor mobilized CD4 T cells. Blood 91: 347-352.
21. Mielcarek, M., L. Graf, G. Johnson, and B. Torok-Storb. 1998. Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediared suppression of T cell proliferation. Blood 92: 215-222.
22. + cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 89: 1629-1634.
23. + T cell apoptosis following stem cell transplantation. Cancer Res. 59: 3107-3111.
24. Rodriguez, P. C., A. H. Zea, J. DeSalvo, K. S. Culotta, J. Zabalera, D. G. Quiceno, J. B. Ochoa, and A. C. Ochoa. 2003. L-arginine consumption by macrophages modulates the expression of CD3 ζ-chain in T lymphocytes. J. Immunol. 171: 1232-1239.
25. Rodriguez, P. C., D. G. Quiceno, J. Zabaleta, B. Ortiz, A. H. Zea, M. B. Piazuelo, A. Delgado, P. Correa, J. Brayer, E. M. Sotomayor, et al. 2004. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T cell receptor expression and antigen-specific T cell responses. Cancer Res. 64: 5839-5849.
26. +NKT cells. J. Immunol. 73: 4960-4966.
27. Tanaka, J., T. Toubai, Y. Tsutsumi, Y. Miura, N. Kato, S. Umehara, K. Kahata, A. Mori, N. Toyoshima, S. Ota, et al. 2004. Cytolytic activity and regulatory functions of inhibitory NK cell receptor-expressing T cells expanded from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 104: 768-774.
28. + regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 64: 8451-8455.
29. +) in the blood of normal donors. Blood 89: 2586-2595.
30. Joshi, S. S., J. C. Lynch, S. Z. Pavletic, S. R. Tarantolo, S. J. Pirruccello, A. Kessinger, and M. R. Bishop. 2001. Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics. Blood 98: 1963-1970.
31. Paust, S., and H. Cantor. 2005. Regulatory T cells and autoimmune disease. Immunol. Rev. 204: 195-207.
32. Rutella, S., S. Danese, and G. Leone. Regulatory T cells for immunotherapy of auto-immune diseases: from the bench to the bedside. Exp. Opin. Ther. Patents. In press.
33. Rutella, S., and R. M. Lemoli. 2004. Regulatory T cells and tolerogenic dendritic cells: from basic biology to clinical applications. Immunol. Lett. 94: 11-26.
34. Jonuleit, H., and E. Schmitt. 2003. The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 171: 6323-6327.
35. Rutella, S., L. Pierelli, G. Bonanno, S. Sica, F. Ameglio, E. Capoluongo, A. Mariotti, G. Scambia, G. d'Onofrio, and G. Leone. 2002. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood 100: 2562-2571.
36. Morris, E. S., K. P. MacDonald, V. Rowe, D. H. Johnson, T. Banovic, A. D, Clouston, and G. R. Hill. 2004. Donor treatment with pegylated G-CSF augments the generation of IL-10-producing regulatory T cells and promotes transplanration tolerance. Blood 103: 3573-3581.
37. Arpinati, M., C. L. Green, S. Heimfeld, J. E. Heuser, and C. Anasetti. 2000. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95: 2484-2490.
38. Pulendran, B., J. Banchereau, S. Burkeholder, E. Kraus, E. Guinet, C. Chalouni, D. Caron, C. Maliszewski, J. Davoust, J. Fay, and K. Palucka. 2000. Flr3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J. Immunol. 165: 566-572.
39. hi blood dendritic cells with altered CD62L and CCR7 expression. Blood 101: 2314-2317.
40. Rutella, S., G. Bonanno, L. Pierelli, A. Mariotti, E. Capoluongo, A. M. Contemi, F. Ameglio, A. Curti, D. G. De Ritis, M. T. Voso, et al. 2004. Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-α. Eur. J. Immunol. 34: 1291-1302.
41. Fagnoni, F. F., B. Oliviero, G. Giorgiani, P. De Stefane, A. Deho, C. Zibera, N. Gibelli, R. Maccario, G. Da Prada, M. Zecca, and F. Locatelli. 2004. Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation. Blood 104: 281-289.
42. Levings, M. K., R. Sangregorio, F. Galbiati, S. Squadrone, R. de Waal Malefyt, and M. G. Roncarolo. 2001. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166: 5530-5539.
43. MacDonald, K. P., V. Rowe, A. D. Clouston, J. K. Welply, R. D. Kuns, J. L. Ferrara, R. Thomas, and G. R. Hill. 2005. Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells. J. Immunol. 174: 1841-1850.
44. Granucci, F., C. Vizzardelli, M. Pavelka, S. Feau, M. Persico, E. Virzi, M. Rescigno, G. Moro, and P. Ricciardi-Castagnoli. 2001. Inducible IL-2 production by dendritic cells revealed by global gene expression analysis. Nat. Immunol. 2: 882-888.
45. Malek, T. R., and A. L. Bayer. 2004. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol 4: 665-674.
46. Young, M. R., and D. M. Larhers. 1999. Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers. Int. J. Immunopharmacol. 21: 241-252.
47. 1 mice pretreated with granulocyte colony-stimulating factor accept parental bone marrow grafts in hybrid resistance system. Blood 89: 1446-1451.
48. Kaneko, H., J. Fujimoto, K. Iizuka, H. Kimura, and Y. Kokai. 1995. Engraftment of rat bone marrow cells in mice transgenic for granulocyte-colony stimulating factor. Transplant. Proc. 27: 1551-1552.
49. Pan, L., J. Delmonte, Jr., C. K. Jalonen, and J. L. Ferrara. 1995. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 86: 4422-4429.
50. Pan, L. T. Teshima, G. R. Hill, D. Bungard, Y. S. Brinson, V. S. Reddy, K. R. Cooke, and J. L. Ferrara. 1999. Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease. Blood 93: 4071-4078.
51. Zeng, D., S. Dejbakhsh-Jones, and S. Strober. 1997. Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation. Blood 90: 453-463.
52. Reddy, V., G. R. Hill, L. Pan, A. Gerbitz, T. Teshima, Y. Brinson, and J. L. Ferrara. 2000. G-CSF modulares cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient. Transplantation 69: 691-693.
53. Champlin, R. E., N. Schmitz, M. M. Horowitz, B. Chapuis, R. Chopra, J. J. Cornelissen, R. P. Gale, J. M. Goldman, F. R. Loberiza, Jr., B. Hertenstein, et al. 2000. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation: IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 95: 3702-3709.
54. Remberger, M., N. Naseh, J. Aschan, L. Barkholt, K. LeBlanc, P. Svennberg, and O. Ringden. 2003. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV. Bone Marrow Transplant. 32: 217-223.
55. Ringden, O., M. Labopin, N. C. Gorin, K. Le Blanc, V. Rocha, E. Gluckman, J. Reiffers, W. Arcese, J. M. Vossen, J. P. Jouet, et al. 2004. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. J. Clin. Oncol. 22: 416-423.
56. Ho, V. T., N. Q. Mirza, D. Junco Dd, T. Okamura, and D. Przepiorka. 2003. The effect of hematopoietic growth factors on the risk of graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis. Bone Marrow Transplant. 32: 771-775.
57. Appelbaum, F. R. 2004. Use of granulocyte colony-stimulating factor following hematopoietic cell transplantation: does haste make waste? J. Clin. Oncol. 22: 390-391.
58. Ringden, O. T., K. Le Blanc, and M. Remberger. 2005. Granulocyte and granulocyte-macrophage colony-stimulating factors in allografts: uses, misuses, misconceptions, and future applications. Exp. Hematol. 33: 505-512.
59. Mohty, M., C. Faucher, and D. Blaise. 2005. Graft-versus-host-disease and granulocyte colony-stimulating factor administration after allogeneic stem cell transplantation. Leukemia 19: 500-503.
60. Lindemann, M., H. Grosse-Wilde, H. D. Ottinger, R. Peceny, and D. W. Beelen. 2005. G-CSF-induced alteration of in vitro alloreactivity in stem cell donors is predictive for the occurrence of acute GVHD in recipients. Transplantation 79: 377-378.
61. Przepiorka, D., P. Anderlini, R. Saliba, K. Cleary, R. Mehra, I. Khouri, Y. O. Huh, S. Giralt, I. Braunschweig, K. van Besien, and R. Champlin. 2001. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 98: 1695-1700.
62. Storek, J., T. Gooley, M. Siadak, W. I. Bensinger, D. G. Maloney, T. R. Chauncey, M. Flowers, K. M. Sullivan, R. P. Witherspoon, S. D. Rowley, et al. 1997. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 90: 4705-4709.
63. Banovic, T., K. P. Macdonald, E. S. Morris, V. Rowe, R. Kuns, A. Don, J. Kelly, S. Ledbetter, A. D. Clouston, and G. R. Hill. 2005. TGF-β in allogeneic stem cell transplantation: friend or foe? Blood 106: 2206-2214.
64. Volpi, I., K. Perruccio, A. Tosti, M. Capanni, L. Ruggeri, S. Posati, F. Aversa, A. Tabilio, L. Romani, M. F. Martelli, and A. Velardi, 2001. Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants. Blood 97: 2514-2521.
65. Hommes, D. W., J. Meenan, S. Dijkhuizen, F. J. Ten Kate, G. N. Tytgat, and S. J. Van Deventer. 1996. Efficacy of recombinant granulocyte colony-stimulating factor (rhG-CSF) in experimental colitis. Clin. Exp. Immunol. 106: 529-533.
66. Egi, H., K. Hayamizu, M. Yoshimitsu, F. Shimamoto, K. Oishi, I. Ohmori, M. Okajima, and T. Asahara. 2003. Regulation of T helper type-1 immunity in hapten-induced colitis by host pretreatment with granulocyte colony-stimulating factor. Cytokine 23: 23-30.
67. Dejaco, C., C. Lichtenberger, W. Miehsler, G. Oberhuber, F. Herbst, H. Vogelsang, A. Gangl, and W. Reinisch. 2003. An open-label pilot study of granulocyte colony-stimulating factor for the treatment of severe endoscopic postoperative recurrence in Crohn's disease. Digestion 68: 63-70.
68. Korzenik, J. R., and B. K. Dieckgraefe. 2005. An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease. Aliment. Pharmacol. Ther. 21: 391-400.
69. Zavala, F., A. Massen, K. Hadaya, S. Ezine, E. Schneider, O. Babin, and J. F. Bach. 1999. Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice. J. Immunol. 163: 5125-5132.
70. Scapini, P., B. Nardelli, G. Nadali, F. Calzetti, G. Pizzolo, C. Montecucco, and M. A. Cassatella. 2003. G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J. Exp. Med. 197: 297-302.
71. Pascual, V., J. Banchereau, and A. K. Palucka. 2003. The central role of dendritic cells and interfeton α in SLE. Curr. Opin. Rheumatol. 15: 548-556.
72. Mackay, F., S. A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp, and J. L. Browning. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190: 1697-1710.
73. 1 but not in BALB/c mice. J. Immunol. 174: 2499-2506.
74. Lawlor, K. E., I. K. Campbell, D. Metcalf, K. O'Donnell, A. van Nieuwenhuijze, A. W. Roberts, and I. P. Wicks. 2004. Critical role for granulocyte colony-stimulating factor in inflammatory arthritis. Proc. Natl. Acad. Sci. USA 101: 11398-11403.
75. Brendolan, A., M. Higuchi, R. Sibley, and S. Strober, 2003. Treatment of adjuvant arthritis with granulocyte-colony stimulating factor and pepride derived from hear shock prorein 65. Cell. Immunol. 221: 6-14.
76. Campbell, I. K., M. J. Rich, R. J. Bischof, and J. A. Hamilton. 2000. The colony-stimulating factors and collagen-induced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J. Leukocyte Biol. 68: 144-150.
77. Miyahara, H., T. Hotokebuchi, I. Saikawa, C. Arita, K. Takagishi, and Y. Sugioka. 1993. The effects of recombinant human granulocyte colony-stimulating factor on passive collagen-induced arthritis transferred with anti-type II collagen antibody. Clin. Immunol. Immunopathol. 69: 69-76.
78. Euler, H. H., P. Harten, R. A. Zeuner, and U. M. Schwab, 1997. Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infections. J. Rheumatol. 24: 2153-2157.
79. Snowden, J. A., J. C. Biggs, S. T. Milliken, A. Fuller, D. Sraniforth, F. Passuello, J. Renwick, and P. M. Brooks. 1998. A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis. Bone Marrow Transplant. 22: 1035-1041.
80. Zavala, F., S. Abad, S. Ezine, V. Taupin, A. Masson, and J. F. Bach. 2002. G-CSF therapy of ongoing experimental allergic encephalomyelitis via chemokine- and cytokine-based immune deviation. J. Immunol. 168: 2011-2019.
81. Lock, C., G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, H. Garren, A. Langer-Gould, S. Strober, B. Cannella, J. Allard, et al. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8: 500-508.
82. Schneider, A., C. Kruger, T. Steigleder, D. Weber, C. Pitzer, R. Laage, J. Aronowski, M. H. Maurer, N. Gassler, W. Mier, et al. 2005. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J. Clin. Invest. 115: 2083-2098.
83. Hadaya, K., H. Kared, A. Masson, L. Chatenoud, and F. Zavala. 2005. G-CSF treatment prevents cyclophosphamide acceleration of autoimmune diabetes in the NOD mouse. J. Autoimmun. 24: 125-134.
84. + regulatory T-cells. Diabetes 54: 78-84.
85. Chatenoud, L., E. Thervet, J. Primo, and J. F. Bach. 1994. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 91: 123-127.
86. Belghith, M., J. A. Bluestone, S. Barriot, J. Megret, J. F. Bach, and L. Chatenoud. 2003. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced, by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 9: 1202-1208.
87. Keymeulen, B., E. Vandemeulebroucke, A. G. Ziegler, C. Mathieu, L. Kaufman, G. Hale, F. Gorus, M. Goldman, M. Walter, S. Candon, et al. 2005. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N. Engl. J. Med. 352: 2598-2608.
88. MacDonald, K. P., V. Rowe, C. Filippich, R. Thomas, A. D. Clouston, J. K. Welply, D. N. Hatt, J. L. Ferrara, and G. R. Hill. 2003. Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation. Blood 101: 2033-2042.
89. high regulatory T cells. Blood 104: 895-903.
90. + myeloid progenitor cells that differentiate in vivo into resting dendritic cells. Diabetes 54: 434-442.
91. Burt, R. K., S. Slavin, W. H. Burns, and A. M. Marmort. 2002. Inducrion of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Int. J. Hematol. 76(Suppl. 1): 226-247.
92. Gabrilovich, D. 2004. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 4: 941-952.
93. Bach, J. F. 2002. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347: 911-920.